Mc Ilrath & Eck, LLC Abbott Laboratories Transaction History

Mc Ilrath & Eck, LLC

$572 Million
Q4 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 1,096 shares of ABT stock, worth $143,554. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,096

Previous 1,122 2.32%

Holding current value

$143,554

Previous $127,000 3.15%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $2,910 - $3,104	-26 Reduced 2.32%	1,096 $123,000
Q3 2024 Nov 19, 2024	BUY	$100.07 - $118.13 $2,601 - $3,071	26 Added 2.37%	1,122 $127,000
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $13,800 - $15,404	-137 Reduced 11.11%	1,096 $113,000
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $16,975 - $18,748	155 Added 14.38%	1,233 $140,000
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $28,117 - $31,328	-279 Reduced 20.56%	1,078 $117,000
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $13,754 - $16,189	142 Added 11.69%	1,357 $137,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $17,871 - $20,965	-188 Reduced 13.4%	1,215 $133,000
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $19,597 - $23,687	-192 Reduced 12.04%	1,403 $152,000
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $2,850 - $3,476	-25 Reduced 1.54%	1,595 $189,000
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $47,367 - $57,998	-410 Reduced 20.2%	1,620 $228,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.05%	2,030 $240,000
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $13,646 - $16,064	-129 Reduced 5.98%	2,029 $235,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $4,353 - $5,129	40 Added 1.89%	2,158 $259,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $17,535 - $19,108	167 Added 8.56%	2,118 $232,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $2,291 - $2,782	25 Added 1.3%	1,951 $212,000
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $4,823 - $6,174	63 Added 3.38%	1,926 $176,000
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $62 - $91	1 Added 0.05%	1,863 $147,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $7,301 - $8,128	93 Added 5.26%	1,862 $162,000
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $41,411 - $44,902	506 Added 40.06%	1,769 $148,000
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $1,920 - $2,321	29 Added 2.35%	1,263 $101,000
Q4 2018 May 07, 2019	SELL	$65.56 - $74.27 $2,884 - $3,267	-44 Reduced 3.44%	1,234 $89,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $6,689 - $8,069	-110 Reduced 7.93%	1,278 $94,000
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $11,571 - $12,771	201 Added 16.93%	1,388 $85,000
Q1 2018 May 22, 2018	SELL	$56.27 - $63.62 $10,466 - $11,833	-186 Reduced 13.55%	1,187 $71,000
Q4 2017 Mar 19, 2018	BUY	$53.68 - $57.47 $73,702 - $78,906	1,373	1,373 $78,000

Others Institutions Holding ABT

# of Institutions

3,411

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account